Integrative Molecular Phenotyping
INTEGRATIVE MOLECULAR
PHENOTYPING
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY

Years

Publications

MP Endsley, MA Isbell, L Cui, CE Wheelock, BD Hammock, JR Falck, WB Campbell, and K Nithipatikom, 2007. Effects of exogenous 2-arachidonoylglycerol hydrolysis and 12-lipoxygenase on prostate carcinoma (PC-3) cell invasion. International Journal of Cancer 121(5):984-991.
CE Wheelock, S Goto, BD Hammock, and JW Newman, 2007. Clofibrate-induced changes in the liver, heart, brain and white adipose lipid metabolome of Swiss-Webster mice. Metabolomics 3(2):137-145.
CJ Hillard, W-S V Ho, J Thompson, K M Gauthier, CE Wheelock, H Huang and BD Hammock, 2007. Effects of catabolic inhibitors on vasodilation of rat middle cerebral artery by the endocannabinoid, 2-arachidonylglycerol. British Journal Pharmacology 152(5):691-698.
T Kadowaki, CE Wheelock, T Adachi, T Kudo, S Okamoto, N Tanaka, K Tonomura, G Tsujimoto, H Mamitsuka, S Goto, and M Kanehisa, 2007. Identification of endocrine disruptor biodegradation by integration of structure-activity relationship with pathway analysis. Environ Science and Technology 41:7997-8003.
J Normark, D Nilsson, U Ribacke, G Winter, K Moll, CE Wheelock, J Bayarugaba, F Kironde, TG Egwang, Q Chen, B Andersson, and M Wahlgren, 2007. PfEMP1 motifs predict severity of Plasmodium falciparum malaria. PNAS 104(40):15835-15840.
RM Wadkins, JL Hyatt, CC Edwards, L Tsurkan, MR Redinbo, CE Wheelock, PD Jones, BD Hammock, and PM Potter, 2007. QSAR analysis of trifluoromethylketone-mediated inhibition of mammalian carboxylesterases. Molecular Pharmacology 71(3):713-723.